Johnson & Johnson announced unaudited consolidated earnings results for the fourth quarter and full year 2018. For the quarter, the company reported sales to customers of $20,394 million against $20,195 million a year ago. Net earnings were $3,042 million or $1.12 per basic and diluted share against loss of $10,713 million or $3.99 per basic and diluted share a year ago.

For the nine months, the company reported sales to customers of $81,581 million against $76,450 million a year ago. Net earnings were $15,297 million or $5.61 per diluted share against $1,300 million or $0.47 per diluted share a year ago.

The company announced its 2019 full-year guidance for sales of $80.4 billion to $81.2 billion reflecting expected operational growth in the range of 0.0% to 1.0%.